Valuation: BioElectronics Corporation

Market Cap 12.35M 11.27M 10.42M 9.4M 17.7M 1.15B 18.4M 126M 49.73M 623M 46.34M 45.37M 1.97B P/E 2020
-26.5x
P/E 2021 -95.5x
Enterprise Value 25.69M 23.43M 21.67M 19.55M 36.82M 2.4B 38.28M 262M 103M 1.3B 96.39M 94.37M 4.09B EV / Sales 2020
53.6x
EV / Sales 2021 24.2x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 week+60.00%
Current month+33.33%
1 month+33.33%
3 months+33.33%
1 week 0
Extreme 0.0002
0
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0002
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 0.0001
0.01
Manager TitleAgeSince
Chief Executive Officer - 2019-11-14
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 85 2020-06-14
Director/Board Member - 2019-11-14
Director/Board Member - 2024-12-02
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+60.00%+33.33%-.--% 6.18M
+0.87%-3.48%+20.26%+48.52% 254B
+1.24%-2.86%+1.36%+10.01% 159B
-2.23%-6.36%-23.01%+37.89% 149B
+1.42%-3.30%-56.02%-19.69% 62.37B
-0.19%-0.55%+25.21%+57.29% 60.62B
+1.25%+0.74%+5.46%-12.39% 53.05B
+2.97%+0.21%+23.28%+56.72% 48.55B
-3.89%-9.05%+1.27%+57.02% 46.7B
+3.63%-1.02%+23.76%+77.98% 44.21B
Average +0.51%-2.59%+5.49%+31.34% 88B
Weighted average by Cap. +0.40%-3.72%+2.85%+34.22%

Financials

2020 2021
Net sales 830K 757K 700K 631K 1.19M 77.52M 1.24M 8.45M 3.34M 41.84M 3.11M 3.05M 132M 1.61M 1.47M 1.36M 1.22M 2.31M 150M 2.4M 16.39M 6.48M 81.18M 6.04M 5.91M 256M
Net income -1.16M -1.06M -978K -883K -1.66M -108M -1.73M -11.81M -4.67M -58.49M -4.35M -4.26M -185M -290K -264K -244K -221K -415K -27.08M -432K -2.95M -1.17M -14.62M -1.09M -1.06M -46.16M
Net Debt 13.07M 11.92M 11.02M 9.94M 18.73M 1.22B 19.47M 133M 52.61M 659M 49.03M 48M 2.08B 13.34M 12.17M 11.25M 10.15M 19.12M 1.25B 19.88M 136M 53.71M 673M 50.05M 49M 2.12B
Logo BioElectronics Corporation
BioElectronics Corporation is an electroceutical company, which develops wearable, neuromodulation devices to safely mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) uses low-power pulsed electromagnetic fields to regulate electrical activity of the nervous system. The Company’s product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. PSWT is a non-invasive electromagnetic therapy designed to reduce pain and enhance life in patients with chronic musculoskeletal conditions. PSWT has no systemic side effects and can be self-administered at home. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more.
Employees
9
Date Price Change Volume
26-11-18 $0.000300 +20.00% 5,266,016
26-11-17 $0.000250 -16.67% 5,676,424
26-11-16 $0.000300 -.--% 14,144,007
26-11-13 $0.000300 -.--% 194,230
26-11-12 $0.000300 +20.00% 585,000
  1. Stock Market
  2. Stocks
  3. BIEL Stock